Beurs gesloten -
OTC Markets
20:09:17 09-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
2,81
USD
|
-48,72%
|
|
-.--%
|
-.--%
|
Fiscaal tijdperk: Januari |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
2027
|
---|
Marktkapitalisatie
1 |
118.587
|
84.773
|
56.092
|
47.323
|
37.882
|
29.374
|
-
|
-
|
Bedrijfswaarde
1 |
108.941
|
76.292
|
54.059
|
41.524
|
34.093
|
29.599
|
32.408
|
35.216
|
K/w-verhouding
|
-22,7
x
|
-25
x
|
-12
x
|
-7,75
x
|
-14
x
|
-8,72
x
|
-8,17
x
|
-9,96
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
265
x
|
-
|
-
|
-
|
-
|
-
|
44,5
x
|
10,4
x
|
Bedrijfswaarde/omzet
|
244
x
|
-
|
-
|
-
|
-
|
-
|
49,1
x
|
12,4
x
|
Bedrijfswaarde/EBITDA
|
-20
x
|
-13,3
x
|
-8,33
x
|
-5,27
x
|
-7,53
x
|
-9,53
x
|
-9,34
x
|
-12,7
x
|
Bedrijfswaarde/FCF
|
-18,7
x
|
-73,7
x
|
-8,17
x
|
-5,58
x
|
-
|
-6,8
x
|
-6,99
x
|
-8,9
x
|
FCF Yield
|
-5,34%
|
-1,36%
|
-12,2%
|
-17,9%
|
-
|
-14,7%
|
-14,3%
|
-11,2%
|
Price to Book
|
11
x
|
10,4
x
|
32,8
x
|
12
x
|
14,9
x
|
-179
x
|
-9,7
x
|
-5,49
x
|
Aantal aandelen (in duizenden)
|
51.785
|
51.785
|
51.793
|
63.606
|
66.929
|
68.630
|
-
|
-
|
Referentieprijs
2 |
2.290
|
1.637
|
1.083
|
744,0
|
566,0
|
428,0
|
428,0
|
428,0
|
Datum van publicatie
|
16/03/20
|
17/03/21
|
11/03/22
|
16/03/23
|
18/03/24
|
-
|
-
|
-
|
Fiscaal tijdperk: Januari |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
2027
|
---|
Omzet
1 |
447,2
|
-
|
-
|
-
|
-
|
-
|
660
|
2.832
|
EBITDA
1 |
-5.446
|
-5.727
|
-6.488
|
-7.875
|
-4.525
|
-3.106
|
-3.468
|
-2.769
|
Bedrijfsresultaat (EBIT)
1 |
-5.486
|
-5.802
|
-6.620
|
-7.899
|
-4.540
|
-4.040
|
-4.230
|
-3.470
|
Operationele Marge
|
-1.226,69%
|
-
|
-
|
-
|
-
|
-
|
-640,97%
|
-122,56%
|
Resultaat voor belastingen (EBT)
1 |
-5.157
|
-3.211
|
-4.560
|
-4.697
|
-2.542
|
-3.532
|
-3.621
|
-3.076
|
Nettowinst (verlies)
1 |
-5.158
|
-3.386
|
-4.677
|
-5.559
|
-2.644
|
-3.295
|
-3.528
|
-2.895
|
Nettomarge
|
-1.153,27%
|
-
|
-
|
-
|
-
|
-
|
-534,57%
|
-102,22%
|
WPA
2 |
-100,9
|
-65,38
|
-90,33
|
-95,99
|
-40,48
|
-49,07
|
-52,40
|
-42,98
|
Free Cash Flow
1 |
-5.813
|
-1.036
|
-6.613
|
-7.444
|
-
|
-4.352
|
-4.635
|
-3.958
|
FCF-marge
|
-1.299,78%
|
-
|
-
|
-
|
-
|
-
|
-702,27%
|
-139,78%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
16/03/20
|
17/03/21
|
11/03/22
|
16/03/23
|
18/03/24
|
-
|
-
|
-
|
Fiscaal tijdperk: Januari |
2020 S2
|
2021 S1
|
2021 S2
|
2022 S1
|
2022 Q3
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 Q4
|
2024 S2
|
---|
Omzet
|
19,46
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
-3.101
|
-2.570
|
-3.232
|
-3.052
|
-1.687
|
-1.844
|
-2.778
|
-4.622
|
-1.783
|
-1.494
|
-1.461
|
-1.623
|
-3.085
|
-640,3
|
-813,7
|
-
|
Operationele Marge
|
-15.936,2%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Resultaat voor belastingen (EBT)
|
-3.109
|
-3.205
|
-6
|
-2.127
|
-886
|
869
|
-
|
-774
|
1.211
|
-
|
-866
|
-
|
-1.858
|
116
|
-
|
-
|
Nettowinst (verlies)
|
-3.109
|
-3.207
|
-178,9
|
-2.134
|
-981
|
-315
|
-
|
-2.154
|
396
|
-
|
-626,2
|
-
|
-1.787
|
-96
|
-
|
-
|
Nettomarge
|
-15.977,31%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
WPA
|
-
|
-61,94
|
-
|
-41,21
|
-18,95
|
-5,980
|
-
|
-39,26
|
8,140
|
-
|
-9,680
|
-
|
-27,59
|
-1,400
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
16/03/20
|
14/09/20
|
17/03/21
|
14/09/21
|
15/12/21
|
14/06/22
|
14/09/22
|
14/09/22
|
15/12/22
|
16/03/23
|
14/06/23
|
14/09/23
|
14/09/23
|
14/12/23
|
18/03/24
|
18/03/24
|
Fiscaal tijdperk: Januari |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
2027
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
226
|
3.034
|
5.843
|
Nettokaspositie
1 |
9.646
|
8.480
|
2.033
|
5.799
|
3.789
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-0,0728
x
|
-0,8748
x
|
-2,11
x
|
Free Cash Flow
1 |
-5.813
|
-1.036
|
-6.613
|
-7.444
|
-
|
-4.352
|
-4.635
|
-3.958
|
ROE (netto-inkomsten/eigen vermogen)
|
-52,4%
|
-35,7%
|
-95,1%
|
-195%
|
-80,5%
|
-191%
|
-958%
|
-
|
ROA (netto-inkomsten/totale activa)
|
-34,8%
|
-45,1%
|
-48,6%
|
-74,8%
|
-46,7%
|
-66,4%
|
-
|
-
|
Totale activa
1 |
14.824
|
7.505
|
9.628
|
7.428
|
5.661
|
4.963
|
-
|
-
|
Nettoactief per aandeel
2 |
209,0
|
157,0
|
33,00
|
62,10
|
38,10
|
-2,400
|
-44,10
|
-78,00
|
Cashflow per aandeel
2 |
-100,0
|
-63,90
|
-87,80
|
-95,60
|
-40,30
|
-44,80
|
-39,10
|
-21,30
|
Capex
1 |
95,7
|
96,2
|
47
|
9
|
-
|
310
|
360
|
410
|
Capex/omzet
|
21,39%
|
-
|
-
|
-
|
-
|
-
|
54,55%
|
14,48%
|
Datum van publicatie
|
16/03/20
|
17/03/21
|
11/03/22
|
16/03/23
|
18/03/24
|
-
|
-
|
-
|
Laatste slotkoers
428
JPY Gemiddelde koersdoel
800
JPY Spread / Gemiddelde doel +86,92% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| +3,91% | 109 mld. | | +10,87% | 105 mld. | | +1,28% | 22,25 mld. | | -13,14% | 22,09 mld. | | -7,05% | 18,68 mld. | | -38,36% | 17,58 mld. | | -10,66% | 16,85 mld. | | +3,75% | 13,76 mld. | | +36,70% | 12,46 mld. |
Biotherapeutische geneesmiddelen
|